Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

OBJECTIVE: The obesity epidemic is a public health concern, warranting further research into pharmacological treatments for weight management (WM) as an adjunct to lifestyle interventions. The Semaglutide Treatment Effect in People with obesity (STEP) program aims to investigate the effect of semagl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Obesity (Silver Spring)
Autores principales: Kushner, Robert F., Calanna, Salvatore, Davies, Melanie, Dicker, Dror, Garvey, W. Timothy, Goldman, Bryan, Lingvay, Ildiko, Thomsen, Mette, Wadden, Thomas A., Wharton, Sean, Wilding, John P.H., Rubino, Domenica
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318657/
https://ncbi.nlm.nih.gov/pubmed/32441473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22794
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares